These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3600 related items for PubMed ID: 8996419

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?
    Westhoff CL.
    Contraception; 1996 Jul; 54(1):1-3. PubMed ID: 8804800
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 27. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
    Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F, Leydon GM.
    Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
    [Abstract] [Full Text] [Related]

  • 30. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O.
    BMJ; 1993 Apr 10; 306(6883):956-63. PubMed ID: 8490470
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP, Encarnacion CE, Chintapalli KN, Rees CR.
    J Am Board Fam Pract; 1997 Apr 10; 10(5):315-21. PubMed ID: 9297655
    [Abstract] [Full Text] [Related]

  • 33. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec 16; 346(8990):1575-82. PubMed ID: 7500748
    [Abstract] [Full Text] [Related]

  • 34. Newer oral contraceptives and the risk of venous thromboembolism.
    Walker AM.
    Contraception; 1998 Mar 16; 57(3):169-81. PubMed ID: 9617533
    [Abstract] [Full Text] [Related]

  • 35. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contracept Technol Update; 1997 Dec 16; 18(12):145-8. PubMed ID: 12348219
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 16; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 180.